A medical knowledge graph is a structured network of biomedical relationships that connects diseases, symptoms, genes, drugs, lab results, and patient histories into a web a computer can reason over. Instead of storing medical data in flat tables or isolated records, a knowledge graph maps how each piece of clinical information relates to every other piece, giving algorithms the context they need to generate personalized recommendations. The concept has moved well beyond theory: researchers have built knowledge graphs from millions of real patient records, used them to predict drug candidates for thousands of diseases, and deployed them in clinical-trial matching systems that process tens of millions of pages of medical text. What makes them especially promising for personalized care is their ability to bring together information that normally lives in separate silos and surface connections no human could spot manually.
How Medical Knowledge Graphs Get Built
Building a medical knowledge graph starts with raw clinical data, most often electronic health records. A literature review of existing approaches found that researchers typically work at three levels: deciding how to represent medical concepts (diseases, symptoms, procedures, drugs), extracting those concepts and their relationships from unstructured text, and filling in gaps where connections are missing but likely.1PubMed. Towards electronic health record-based medical knowledge graph construction, completion, and applications: A literature study The representation step usually leans on existing medical vocabularies. The Unified Medical Language System, or UMLS, is one of the most common backbones; it provides standardized codes and relationships for clinical terms so that “heart attack” and “myocardial infarction” map to the same concept.2arXiv. Integration of Domain Knowledge using Medical Knowledge Graph Deep Learning for Cancer Phenotyping SNOMED-CT, another widely used clinical terminology system, serves a similar anchoring role, particularly for primary care data.3PubMed Central. RECAP-KG: Mining Knowledge Graphs from Raw Primary Care Physician Notes for Remote COVID-19 Assessment in Primary Care
The harder challenge is extraction. Doctors write clinical notes in free text full of abbreviations, negations, and implicit context. Modern systems use language models to pull named entities (a drug name, a diagnosis, a lab value) from those notes and then classify how they relate to each other. One framework tested on over 500 real patient records achieved about 91% accuracy for identifying medical entities and 88% for extracting the relationships between them.4Computer Methods and Programs in Biomedicine Update. BERT based clinical knowledge extraction for biomedical knowledge graph construction and analysis Those numbers are encouraging, but they also mean roughly one in ten entities still gets missed or misclassified, which is why human review remains part of most pipelines.
To get these graphs working at hospital scale, interoperability matters. One system called FHIR-Ontop-OMOP demonstrated how to generate a virtual clinical knowledge graph from a standardized hospital database, mapping over 100 clinical data elements across patient records, conditions, procedures, medications, and observations. Testing confirmed that patient counts from traditional database queries and from knowledge-graph queries matched exactly, which is the kind of fidelity hospitals need before trusting these systems.5PubMed Central. FHIR-Ontop-OMOP: Building clinical knowledge graphs in FHIR RDF with the OMOP Common data Model
Finding New Uses for Existing Drugs
One of the most immediately valuable applications of medical knowledge graphs is drug repurposing: figuring out whether a medication already approved for one condition might work for another. This matters because developing a brand-new drug takes over a decade on average and costs billions. If a knowledge graph can flag a plausible candidate that already has safety data, the path to the clinic gets dramatically shorter.
A system called TXGNN, trained on a medical knowledge graph, uses a graph neural network to rank drugs as potential treatments or contraindications across over 17,000 diseases. In head-to-head benchmarks against eight other methods, it improved prediction accuracy for new drug indications by about 49% and for contraindications by about 35%, both under strict zero-shot conditions where the model had never seen training examples for those diseases.6PubMed Central. A foundation model for clinician-centered drug repurposing That zero-shot capability is what makes this approach relevant for rare diseases, where labeled training data is scarce or nonexistent.
A separate framework called KG-Predict took a complementary approach, building a knowledge graph from genotypic and phenotypic databases that contained over 1.2 million associations among more than 61,000 entities. It learned representations of drugs, diseases, genes, and their interactions and used those to infer new drug-disease links.7PubMed Central. KG-Predict: A knowledge graph computational framework for drug repurposing The value here isn’t just finding one promising candidate; it’s systematically screening thousands of possibilities in ways that would be impossible with traditional lab methods alone.
Spotting Dangerous Drug Interactions
When you take multiple medications, each additional drug increases the chance that two or more will interact in harmful ways. This is a persistent problem in healthcare, especially for older adults who often take five or more daily medications. Knowledge graphs offer a structural advantage here because drug interactions are fundamentally about relationships, and relationship mapping is exactly what graphs do well.
A method called KnowDDI uses graph neural networks to build richer representations of each drug by pulling in information from its neighborhood in a large biomedical knowledge graph. For each pair of drugs, the system then learns a “knowledge subgraph” that highlights which known interactions and molecular similarities are most relevant to predicting whether the pair will cause problems. This approach also offers interpretability: clinicians can inspect the subgraph and see why the model flagged a particular combination.8Communications Medicine. Accurate and interpretable drug-drug interaction prediction enabled by knowledge subgraph learning
Graph-based models are also being developed specifically for polypharmacy risk, where the goal is predicting adverse reactions from multi-drug regimens rather than just pairwise interactions. In these models, each drug is represented as a node and pharmacological relationships as edges, allowing the system to propagate information across the entire drug network and flag patterns that two-at-a-time analysis would miss.9DMPedia Lecture Notes in Computer Science & Engineering. AI-Driven Polypharmacy Risk Prediction Using Graph Neural Networks For a patient on eight medications, the number of possible three-way and four-way interactions is enormous, and these are exactly the scenarios where graph-based reasoning has an edge over simpler lookup-table approaches.
Diagnosing Rare Diseases
Rare diseases are notoriously difficult to diagnose. There are thousands of them, most are genetic, and the average time from first symptoms to correct diagnosis stretches years in many cases. Medical knowledge graphs can help by connecting observed symptoms (phenotypes) to the genes most likely responsible, narrowing the search space for clinicians and geneticists.
A recent study built a hypergraph linking over 2,100 diseases, 4,600 genes, and 9,500 phenotypes drawn from established rare-disease databases. When tested on its ability to identify the causal gene for a given set of symptoms, the system placed the correct gene in its top 10 predictions for half of all test cases and in the top 100 for 85% of cases. At the very top of the ranking, the single best-predicted gene was correct for about 98% of diseases tested.10PubMed Central. A Hypergraph powered approach to Phenotype-driven Gene Prioritization and Rare Disease Prediction These numbers represent meaningful improvements over earlier graph-based methods, and they illustrate why knowledge graphs have become a go-to tool for rare disease researchers who need to prioritize which genes to sequence first.
Gene-disease prediction also benefits from knowledge graph embedding methods, where the graph’s structure gets compressed into mathematical representations that capture hidden relationships. One study applied embedding techniques to a biomedical knowledge graph and achieved strong performance in predicting gene-disease associations. An analysis of predictions related to Autism Spectrum Disorder showed the model’s top candidates aligned with known candidate genes and biological pathways, suggesting the embeddings were capturing real biology rather than statistical noise.11Expert Systems. Biomedical knowledge graph embeddings for personalized medicine: Predicting disease‐gene associations
Matching Patients to Clinical Trials
Finding the right clinical trial for a given patient is a surprisingly manual process. Eligibility criteria are written in dense medical language, patient records are scattered across systems, and oncology alone has thousands of active trials at any given time. Knowledge graphs are starting to automate this matching at a scale human coordinators cannot reach.
AIMedGraph, a precision-medicine knowledge graph, illustrates the scope of what these systems integrate: its current release includes over 30,000 diseases and phenotypes, 26,000 genes, 187,000 genetic variants, 2,800 drugs, and 15,000 clinical trials, all linked together with supporting literature.12PubMed Central. AIMedGraph: a comprehensive multi-relational knowledge graph for precision medicine Having all of this connected means that when a patient’s genomic profile and diagnosis are entered, the system can traverse from their specific mutation to relevant trials without anyone manually cross-referencing databases.
A prospective evaluation in oncology took this further. A multi-agent AI system combining large language models with an oncology-specific knowledge graph processed over 157,000 clinical pages across 3,804 patients to perform automated trial matching. Ablation experiments confirmed that grounding the language model’s reasoning in the knowledge graph materially improved both accuracy and efficiency compared to using either component alone.13PubMed Central. Transforming oncology clinical trial matching through neuro-symbolic, multi-agent AI and an oncology-specific knowledge graph: a prospective evaluation in 3804 patients This matters because the bottleneck for many patients isn’t that a matching trial doesn’t exist; it’s that nobody has time to find it.
Making Predictions Doctors Can Actually Trust
A recurring concern with AI in medicine is the black-box problem: if a model recommends a treatment or flags a risk but cannot explain why, clinicians are understandably reluctant to act on it. Knowledge graphs have a structural advantage here because their predictions are inherently traceable. When a system says “this patient is at risk for condition X,” it can point to the specific path through the graph that led to that conclusion, showing which symptoms connected to which diseases through which intermediate nodes.
A system called KGxDP demonstrated this on large public datasets of intensive-care records. It outperformed existing models at predicting patients’ future diseases and, critically, it could extract the reasoning paths within the knowledge graph that led to each prediction. When those extracted paths were fed into a language model as prompts, the model generated natural-language explanations that clinicians could read and evaluate.14Knowledge-Based Systems. Interpretable Disease Prediction via Path Reasoning over medical knowledge graphs and admission history This is a genuinely different approach from trying to explain a neural network after the fact. The graph’s structure makes the reasoning visible by design rather than requiring a separate interpretation layer bolted on later.
Temporal modeling adds another dimension. Patients change over time, and a snapshot-based model misses the trajectory. Researchers have modeled individual patient records as temporal heterogeneous graphs, where each historical visit becomes a node connected to the medical events it contains, and time-aware connections capture how a patient’s health status evolves.15PubMed Central. Predictive Modeling with Temporal Graphical Representation on Electronic Health Records A temporal knowledge graph built specifically for pneumonia patients demonstrated a similar idea, integrating graph networks with recurrent models and attention mechanisms to capture how clinical events progress over a hospital stay.16PubMed. CTKGR: temporal knowledge graph enhanced prediction of in-hospital events for pneumonia patients using electronic health records Modeling the timeline, not just the facts, is essential for personalized predictions because two patients with identical diagnoses but different trajectories may need very different interventions.
Keeping Knowledge Fresh and Private
Medical knowledge changes constantly. New drug interactions are discovered, treatment guidelines are revised, and diagnostic criteria evolve. A knowledge graph that is accurate today can become misleading next year if nobody updates it. Traditional updating methods rely on batch reprocessing or manual curation, both slow and expensive.
A recent approach reframes large language models not as generators of new medical knowledge but as controllers that decide how the graph should be updated at each step. Given a piece of candidate knowledge, the model chooses to add it, revise an existing fact, decay outdated information, or reject the candidate entirely, based on how well it fits the existing graph and how medical understanding has shifted over time.17Scientific Reports. Dynamic medical knowledge graph updating method based on LLM decision control This “controller, not creator” framing is a meaningful safety distinction. The model is not hallucinating new medical facts; it is making structured decisions about whether incoming evidence should change what the graph already contains.
Privacy is the other persistent challenge. Medical knowledge graphs are most useful when they draw on data from many patients and institutions, but sharing patient-level data across hospital boundaries raises obvious concerns. Federated learning offers one solution: instead of centralizing the data, each institution trains knowledge graph embeddings locally and shares only the learned representations with a central server that aligns them. A framework called FPKS demonstrated this approach, maintaining separate embedding tables for entities and relationships on the server while keeping raw patient data at each hospital.18ACM Transactions on Internet Technology. Enhancing Privacy-Preserving Knowledge Graph Embeddings with Federated Learning for IoT Services The trade-off is that federated approaches can lose some accuracy compared to centralized training, but for sensitive medical data, that trade-off is often worth making.
When Large Language Models Meet Knowledge Graphs
Large language models like GPT-4 are impressive at understanding medical text, but they also hallucinate, confidently generating plausible-sounding answers that are factually wrong. Knowledge graphs offer a corrective. By retrieving verified medical facts from a structured knowledge base and injecting them into the model’s prompt before it generates an answer, systems can ground LLM outputs in curated evidence.
A retrieval-augmented generation approach called MKRAG demonstrated this on medical question answering. By pulling relevant facts from an external medical knowledge base and adding them to the prompt, a relatively small language model saw its accuracy improve from about 44% to nearly 49%.19PubMed Central. MKRAG: Medical Knowledge Retrieval Augmented Generation for Medical Question Answering That gain might seem modest in percentage terms, but in medicine, the difference between a correct and incorrect answer can be the difference between the right treatment and a dangerous one. And because the retrieved facts are traceable, clinicians can verify the sources the model relied on, which is impossible with a standard chatbot.
Social Determinants and the Limits of Clinical Data Alone
Most medical knowledge graphs focus on biological and clinical entities: diseases, genes, drugs, lab values. But a patient’s health is also shaped by where they live, their income, their access to transportation, and their social support. These social determinants of health are well-documented drivers of outcomes, yet they remain underrepresented in the structured graphs researchers build.
One study began to address this gap by constructing a knowledge graph enriched with social determinants of health, linking that social data to the MIMIC-III clinical dataset and an existing biomedical graph called PrimeKG.20PubMed Central. Integrating Social Determinants of Health into Knowledge Graphs: Evaluating Prediction Bias and Fairness in Healthcare The study explicitly evaluated whether including social factors introduced or reduced bias in the graph’s predictions, which is the right question to ask. A model that predicts disease risk accurately for affluent patients but poorly for low-income patients is not just unfair; it is clinically dangerous. Adding social context has the potential to improve predictions for underserved populations, but only if the added data is representative and the model is carefully evaluated for fairness across groups.
On the patient-facing side, knowledge graphs combined with language models have been proposed as tools for improving health literacy. The HEALIE Knowledge Graph, for example, was designed to represent cognitive factors that affect how people understand health information, including socioeconomic dimensions. When combined with a large language model, it generated personalized health content tailored to an individual’s background and literacy level.21PubMed. Enhancing Patient Empowerment and Health Literacy: Integrating Knowledge Graphs with Language Models for Personalized Health Content Delivery This is still at the conceptual stage, but it points toward a future where the same knowledge graph infrastructure powering clinician tools also helps patients understand their own conditions in language that makes sense to them.
Real-World Deployment at Scale
For all the promising research, the question that matters most is whether these systems work on real hospital data at real scale. One of the largest reported deployments built a medical knowledge graph from over 16 million de-identified clinical visits across nearly 3.8 million patients. The resulting graph contained about 22,500 entities and 579,000 relationship quadruplets spanning nine entity types. When used to power a clinical search and recommendation system, it improved the quality of results substantially compared to standard keyword-matching methods.22Artificial Intelligence in Medicine. Real-world data medical knowledge graph: construction and applications
These numbers reveal something important about the current state of the field. The raw data volume is enormous, but the resulting knowledge graph is comparatively compact. Millions of records distill into tens of thousands of entities because the graph captures generalizable medical relationships, not individual patient records. This compression is what makes reasoning efficient, but it also means the graph is only as good as the extraction pipeline that built it. Errors in entity recognition or relationship classification propagate through every downstream application, from drug repurposing to clinical trial matching. The 88-91% extraction accuracy mentioned earlier is strong but not perfect, and at hospital scale, even a small error rate affects thousands of inferred relationships.
Knowledge graphs also find applications beyond direct patient care. One oncology hospital used graph technology to model and simulate its own business entities, mapping how organizational units, clinical pathways, and operational processes connect and influence each other. The graph allowed administrators to simulate the impact of organizational changes before implementing them, improving strategic planning and operational resilience.23Value in Health. Use of Knowledge Graphs to Enhance Understanding and Simulation of Corporate Information in an Oncology Hospital It is a reminder that the “graph” part of “knowledge graph” is a general-purpose structure. The same technology that maps gene-disease-drug relationships can map hospital workflows, supply chains, or referral networks. For healthcare systems under constant pressure to do more with less, that flexibility has real institutional value.